Evidence map›Paper›PMID 29167552›Full record

Trial reportJournal of human genetics2018

Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population.

Aya Kawasaki, Keita Yamashita, Fumio Hirano, Ken-Ei Sada, Daisuke Tsukui, Yuya Kondo, Yoshitaka Kimura, Kurumi Asako, Shigeto Kobayashi, Hidehiro Yamada and 14 more

Abstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 1 country.

Aya KawasakiMolecular and Genetic Epidemiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Keita YamashitaMolecular and Genetic Epidemiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Fumio HiranoDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Ken-Ei SadaDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Daisuke TsukuiDepartment of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Yuya KondoDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Yoshitaka KimuraDepartment of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Kurumi AsakoDepartment of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Shigeto KobayashiDepartment of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan.
Hidehiro YamadaDepartment of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Hiroshi FurukawaMolecular and Genetic Epidemiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.ORCID http://orcid.org/0000-0002-4022-0767
Kenji NagasakaDepartment of Rheumatology, Ome Municipal General Hospital, Ome, Japan.
Takahiko SugiharaDepartment of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Kunihiro YamagataDepartment of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Takayuki SumidaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Shigeto TohmaClinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan.
Hajime KonoDepartment of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Shoichi OzakiDepartment of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Seiichi MatsuoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hiroshi HashimotoJuntendo University School of Medicine, Tokyo, Japan.
Hirofumi MakinoOkayama University Hospital, Okayama, Japan.
Yoshihiro ArimuraDepartment of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan.
Masayoshi HarigaiDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Naoyuki TsuchiyaMolecular and Genetic Epidemiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. tsuchiya-tky@umin.net.ORCID http://orcid.org/0000-0002-6776-5580
University of Tsukuba · JPTeikyo University · JPJuntendo University · JPSt. Marianna University School of Medicine · JPTokyo Medical and Dental University · JPKyorin University · JPNagoya University · JPNational Sagamihara Hospital · JPOkayama University · JPOkayama University Hospital · JPOme Municipal General Hospital · JPTokyo Metropolitan Geriatric Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ETS proto-oncogene 1, transcription factor (ETS1) is involved in various immune responses. Genome-wide association studies on systemic lupus erythematosus in Chinese populations identified the association of ETS1 polymorphism in 3' untranslated region, rs1128334A, which was associated with lower ETS1 expression. In view of substantial sharing of susceptibility genes across multiple autoimmune diseases, we examined whether ETS1 is associated with a rare autoimmune rheumatic disease, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Association of rs1128334 was tested in 466 Japanese patients with AAV and 1099 healthy controls by logistic regression analysis under the additive model. AAV patients were classified into 285 microscopic polyangiitis (MPA), 92 granulomatosis with polyangiitis (GPA), 56 eosinophilic GPA, and 33 unclassifiable AAV, according to the European Medicines Agency (EMEA) algorithm. Among the patients, 376 were positive for MPO-ANCA and 62 for PR3-ANCA. When the patients were classified according to the EMEA classification, rs1128334A allele was significantly increased in GPA (P = 0.0060, P

Indexed as

3' Untranslated RegionsPolymorphism, GeneticAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAsian PeopleFemaleGranulomatosis with PolyangiitisHumansJapanMaleProto-Oncogene MasProto-Oncogene Protein c-ets-13' Untranslated RegionsETS1 protein, humanMAS1 protein, humanProto-Oncogene MasProto-Oncogene Protein c-ets-1

Identifiers

PMID29167552
OpenAlexW2762442505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.